| ABIVAX SA SP.ADR O.N. |
| USA |
| Gesundheit |
| US00370M1036 / A3EWCP |
| 2X10 (Frankfurt) / ABVX (NASDAQ) |
| FRA:2X10, ETR:2X10, 2X10:GR, NASDAQ:ABVX |
| - |
| https://www.abivax.com/ |
|
ABIVAX Société Anonyme, a clinical-stage biotech..
>Volltext.. |
| 9021.25 Mio. EUR |
| 9044.87 Mio. EUR |
| - |
| - |
| - |
| - |
| 84.86 Mio. EUR |
| 61.15 Mio. EUR |
| - |
| 0.54 |
| - |
| - |
| - |
| - |
| - |
| - |
| ABIVAX ADR, ABIVAX |
| 17.12.25 |
|